Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations (NCT07629830) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations
Israel220 participantsStarted 2026-07-01
Plain-language summary
Asthma exacerbations leading to emergency department visits or hospitalization are associated with a high risk of recurrent exacerbations, poor disease control, and increased healthcare utilization in the months following discharge. Early specialist follow-up during this vulnerable transition period remains limited, and many patients do not receive optimized long-term asthma management. The purpose of this study is to evaluate whether a structured remote asthma clinic intervention initiated shortly after hospital discharge can reduce recurrent exacerbations and improve asthma-related outcomes compared to standard community care.
This prospective randomized study will enroll 220 adult patients (18-75 years) presenting to the emergency department at Tel Aviv Sourasky Medical Center with an asthma exacerbation. Participants will be randomly assigned to one of two groups:
1. Intervention group - will undergo two structured remote pulmonology follow-up visits via secure video consultation within 7-21 days and 5 months after discharge, including treatment optimization, inhaler technique assessment, and self-management education.
2. Control group - will continue standard community care without additional intervention.
All participants will complete scheduled follow-up assessments over 12 months, including evaluation of exacerbations, asthma control, healthcare utilization, and medication use.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Presentation to the emergency department with an asthma exacerbation.
* Ability to complete telephone follow-up and access to a personal e-mail account.
* Agreement to participate in the study.
* Written or verbal informed consent according to study group assignment.
Exclusion Criteria:
* Uncontrolled cardiac disease.
* Any other uncontrolled medical condition.
* Inability to complete telephone follow-up.
* Pregnancy.
* Patients lacking decision-making capacity.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focuses on reducing repeat asthma attacks through a telecare clinic after an acute episode — since it hasn't started recruiting yet, how much longer might it be before it opens, and is there anything I should be doing in the meantime to reduce my risk of another attack?
2The trial is measuring how often asthma exacerbations happen — what does my current exacerbation history look like, and does that make a post-exacerbation telecare program like this one something worth considering for me?
3Since this study involves telecare rather than in-person visits, what kind of technology access or comfort level would I likely need, and do you think that format would actually work for managing my asthma?
4This trial is listed as 'not yet recruiting' and has no assigned phase — does that mean the safety and structure of this type of intervention are still being worked out, and how does that compare to standard follow-up care I could get right now after an asthma attack?
5Are there existing telehealth or post-exacerbation follow-up programs already available to me that are similar to what this trial is testing, so I can get better asthma management support while waiting to see if this study becomes an option?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.